Tyrosine dephosphorylation, but not phosphorylation, of p130(Cas) is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: Implication of p130(Cas) involvement in pathways unrelated to cytoskeletal reorganization
T. Ohmori et al., Tyrosine dephosphorylation, but not phosphorylation, of p130(Cas) is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: Implication of p130(Cas) involvement in pathways unrelated to cytoskeletal reorganization, BIOCHEM, 39(19), 2000, pp. 5797-5807
The newly described adapter molecule p130 Crk-associated substrate (Cas) ha
s been reported to contribute to cytoskeletal organization through assembly
of actin filaments and to be pivotal in embryonic development and in oncog
ene-mediated transformation. We characterized the regulation of Cas tyrosin
e phosphorylation in highly differentiated, anucleate platelets. Phospholip
ase C-activating receptor agonists, including collagen, thrombin receptor-a
ctivating peptide (TRAP), and U46619 (a thromboxane A(2) analogue), and A23
187 (a Ca2+ ionophore) induced rapid Cas tyrosine phosphorylation in platel
ets. 12-O-Tetradecanoylphorbol 13-acetate and 1-oleoyl-2-acetyl-sn-glycerol
, protein kinase C (PKC) activators, also induced Cas tyrosine phosphorylat
ion, albeit sluggishly. Cas tyrosine phosphorylation induced by collagen or
TRAP was transient in aggregating platelets; Cas became dephosphorylated i
n a manner dependent on integrin alpha IIb beta 3-mediated aggregation. Whi
le BAPTA-AM (an intracellular Ca2+ chelator) inhibited Cas phosphorylation
induced by collagen or TRAP, Ro31-8220 (a PKC inhibitor) rather prolonged i
t. Under the conditions, this PKC inhibitor suppressed platelet aggregation
but not intracellular Ca2+ mobilization. In contrast to Cas involvement in
focal adhesions in other cells, platelet Cas phosphorylation preceded the
activation of focal adhesion kinase (FAK), and blockage of alpha IIb beta 3
-mediated platelet aggregation with a GRGDS peptide resulted in prolongatio
n of stimulation-dependent Cas tyrosine phosphorylation but in suppression
of FAK tyrosine phosphorylation. Furthermore, TRAP-induced Cas phosphorylat
ion was insensitive to cytochalasin D, an actin polymerization inhibitor. T
he failure of FAK to associate with Cas in immunoprecipitation studies also
suggests that Cas tyrosine phosphorylation is independent of FAK activatio
n. Of the signaling molecules investigated in this study, Src seemed to ass
ociate with Gas. Finally, Cas existed mainly in cytosol and membrane cytosk
eleton fractions in the resting state, and remained unchanged during platel
et aggregation, when FAK translocated to the cytoskeletal fraction. Our fin
dings on platelet Cas suggest that (i) rapid Cas tyrosine phosphorylation o
ccurs following phosphoinositide turnover by receptor-mediated agonists and
may be mediated by intracellular Ca2+ mobilization; (ii) PKC activation, b
y itself, may elicit sluggish Cas phosphorylation; (iii) Cas tyrosine depho
sphorylation, but not phosphorylation, is dependent on integrin alpha IIb b
eta 3-mediated aggregation, and (iv) Cas is not involved in cytoskeletal re
organization. Anucleate platelets seem to provide a unique model system to
fully elucidate the functional role(s) of Cas.